Back to Semaglutide research
semaglutide glp 1 agonist rct 2023-04-14 ClinicalTrials

Fiber Supplement Boosts Semaglutide Weight Loss in Overweight and Obese Adults

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity

Background

Obesity and overweight are major global health challenges, often managed with medications like Semaglutide, a GLP-1 receptor agonist known for promoting significant weight loss. While effective, there's a continuous need for strategies to enhance its efficacy and improve patient outcomes. This study specifically investigated whether combining Semaglutide with a multi-component dietary fiber supplement (Soloways) could provide additional benefits for weight reduction and metabolic health in adults.


semaglutide glp 1 agonist glp-1r
Source: clinicaltrials:NCT06215196 · Ingested 2026-04-08 · Digest: gemini-2.5-flash